Application | Comment | Organism |
---|---|---|
medicine | enoyl-acyl carrier protein reductase inhibitors turn out to be clinically useful antimicrobials | Escherichia coli |
medicine | enoyl-acyl carrier protein reductase inhibitors turn out to be clinically useful antimicrobials | Mycobacterium tuberculosis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
diazaborine | - |
Escherichia coli | |
diazaborine | - |
Mycobacterium tuberculosis | |
isoniazid | - |
Escherichia coli | |
isoniazid | - |
Mycobacterium tuberculosis | |
triclosan | - |
Escherichia coli | |
triclosan | - |
Mycobacterium tuberculosis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
trans-2,3-dehydracyl-[acyl-carrier protein] + NADH + H+ | Escherichia coli | - |
acyl-[acyl-carrier protein] + NAD+ | - |
? | |
trans-2,3-dehydracyl-[acyl-carrier protein] + NADH + H+ | Mycobacterium tuberculosis | - |
acyl-[acyl-carrier protein] + NAD+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Escherichia coli | - |
- |
- |
Mycobacterium tuberculosis | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
trans-2,3-dehydracyl-[acyl-carrier protein] + NADH + H+ | - |
Escherichia coli | acyl-[acyl-carrier protein] + NAD+ | - |
? | |
trans-2,3-dehydracyl-[acyl-carrier protein] + NADH + H+ | - |
Mycobacterium tuberculosis | acyl-[acyl-carrier protein] + NAD+ | - |
? |
Synonyms | Comment | Organism |
---|---|---|
enoyl-acyl carrier protein reductase | - |
Escherichia coli |
enoyl-acyl carrier protein reductase | - |
Mycobacterium tuberculosis |
ENR | - |
Escherichia coli |
ENR | - |
Mycobacterium tuberculosis |
FabI | - |
Escherichia coli |
InhA | - |
Mycobacterium tuberculosis |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADH | - |
Escherichia coli | |
NADH | - |
Mycobacterium tuberculosis |